| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |